Key result
Parasympathetic blockade with atropine attenuated the ethnic difference in pancreatic polypeptide secretion (P=0.01) but not in early insulin secretory responses (P=0.6) between Pima Indians and Caucasians.
Why the study?
Does parasympathetic blockade with atropine attenuate hyperinsulinemia and pancreatic polypeptide secretion in Pima Indians compared to Caucasians?
Does parasympathetic blockade with atropine attenuate hyperinsulinemia and pancreatic polypeptide secretion in Pima Indians compared to Caucasians?
p-value: p=0.01 for PP; 0.6 for insulin
Parasympathetic blockade with atropine attenuates the exaggerated pancreatic polypeptide response in Pima Indians but does not reduce their hyperinsulinemia, suggesting vagal input is not the primary driver of their increased insulin secretion.
Does not support parasympathetic blockade for hyperinsulinemia in Pima Indians; leaves open non-vagal mechanisms for ethnic differences in insulin secretion.
There is evidence from animal models of obesity and type 2 diabetes that increased parasympathetic vagal input to the pancreas contributes to hyperinsulinemia. Compared with Caucasians, Pima Indians have a high risk of type 2 diabetes and exhibit marked hyperinsulinemia and elevated plasma levels of pancreatic polypeptide (PP), an islet hormone considered a surrogate marker of parasympathetic nervous system (PNS) drive to the pancreas. To test if hyperinsulinemia in Pima Indians is due to increased vagal input to the beta-cell, we examined the effect of PNS blockade in 17 Caucasian (aged 35 +/- 8 years, body fat 23 +/- 7% [mean +/- SD]) and 17 Pima Indian males (aged 28 +/- 8 years, body fat 29 +/- 5%) with normal glucose tolerance. Each participant underwent four consecutive standardized liquid meal tests (64% carbohydrate, 22% fat, and 14% protein) during which a primed infusion of atropine was administered for 120 min at the following doses: 0, 2.5, 5, and 10 micro g. kg fat-free mass (FFM)(-1). h(-1). Areas under the curve for early (AUC(0-30 min)) and total (AUC(0-120 min)) postprandial insulin and PP secretory responses were calculated. Early postprandial insulin and PP secretory responses were higher in Pima Indians compared with those of Caucasians (both P = 0.01). Secretion of insulin and PP was inhibited by atropine (both P < 0.001). Increasing doses of atropine attenuated the ethnic difference in PP (P = 0.01) but not in early insulin secretory responses (P = 0.6), an effect that was not due to differences in gastric emptying rate (acetaminophen test) and/or circulating glucose. Similar results were observed for total secretory responses. These results confirm that compared with Caucasians, Pima Indians have an exaggerated PNS drive to pancreatic F-cells that secrete PP. However, the hyperinsulinemia of this population does not appear to be due to increased vagal input to pancreatic beta-cells.
No takes yet. Share an insight, caveat, or question.
Courten et al. (2004) studied Normal glucose tolerance (n=34). Atropine infusion vs. 0 dose (baseline) and between ethnicities was evaluated on Attenuation of ethnic difference in early insulin secretory responses and pancreatic polypeptide (PP) (p=0.01 for PP; 0.6 for insulin). Parasympathetic blockade with atropine attenuated the ethnic difference in pancreatic polypeptide secretion (P=0.01) but not in early insulin secretory responses (P=0.6) between Pima Indians and Caucasians.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: